Achieve Life Sciences, Inc.
ACHV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $113 | $82 | $26 | $63 |
| - Cash | $13 | $16 | $25 | $43 |
| + Debt | $10 | $17 | $16 | $0 |
| Enterprise Value | $110 | $83 | $17 | $20 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$37 | -$27 | -$40 | -$33 |
| % Margin | – | – | – | – |
| Net Income | -$40 | -$30 | -$42 | -$33 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.24 | -1.5 | -3.95 | -4.05 |
| % Growth | 17.3% | 62% | 2.5% | – |
| Operating Cash Flow | -$30 | -$24 | -$38 | -$29 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$30 | -$25 | -$38 | -$29 |